These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 21766210

  • 1. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
    Sung H, Lee KM, Choi JY, Han S, Lee JY, Li L, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D.
    Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
    [Abstract] [Full Text] [Related]

  • 2. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
    Han S, Lee KM, Choi JY, Park SK, Lee JY, Lee JE, Noh DY, Ahn SH, Han W, Kim DH, Hong YC, Ha E, Yoo KY, Kang D.
    Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [Abstract] [Full Text] [Related]

  • 5. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women.
    Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T.
    Breast Cancer Res Treat; 2010 Oct; 123(3):885-93. PubMed ID: 20180013
    [Abstract] [Full Text] [Related]

  • 6. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K.
    Cancer Res; 2004 Dec 15; 64(24):8891-900. PubMed ID: 15604249
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG, Baddi L, Liu J, Rosman D, Phukan S, Bradley C, Hegarty C, McDaniel B, Rademaker A, Oddoux C, Ostrer H, Michel LS, Huang H, Chen Y, Ahsan H, Offit K, Pasche B.
    Cancer Res; 2005 Apr 15; 65(8):3454-61. PubMed ID: 15833881
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.